{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:16:13Z","timestamp":1794446173420,"version":"4.9.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"University Grants Committee Research Grants Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","aaojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ophtha.2024.03.013","type":"journal-article","created":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T02:54:34Z","timestamp":1710557674000},"page":"1011-1020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Five-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study"],"prefix":"10.1016","volume":"131","author":[{"given":"Xiu Juan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8515-3388","authenticated-orcid":false,"given":"Yuzhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin H.K.","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Wai","family":"Kam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangtian","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy P.H.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4365-3218","authenticated-orcid":false,"given":"Alvin L.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7201-1900","authenticated-orcid":false,"given":"Pei-Chang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4407-6907","authenticated-orcid":false,"given":"Clement C.","family":"Tham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Pui","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2156-1486","authenticated-orcid":false,"given":"Jason C.","family":"Yam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9827","key":"10.1016\/j.ophtha.2024.03.013_bib1","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/S0140-6736(12)60272-4","article-title":"Myopia","volume":"379","author":"Morgan","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ophtha.2024.03.013_bib2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/aos.14350","article-title":"High prevalence of myopia in children and their parents in Hong Kong Chinese Population: the Hong Kong Children Eye Study","volume":"98","author":"Yam","year":"2020","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"10.1016\/j.ophtha.2024.03.013_bib3","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1136\/bjophthalmol-2021-319307","article-title":"Myopia incidence and lifestyle changes among school children during the COVID-19 pandemic: a population-based prospective study","volume":"106","author":"Zhang","year":"2022","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ophtha.2024.03.013_bib4","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from\u00a02000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ophtha.2024.03.013_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1167\/iovs.61.4.49","article-title":"The complications of myopia: a review and meta-analysis","volume":"61","author":"Haarman","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ophtha.2024.03.013_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2)","volume":"119","author":"Chia","year":"2012","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ophtha.2024.03.013_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-Concentration Atropine for Myopia Progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ophtha.2024.03.013_bib8","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ophtha.2019.12.011","article-title":"Two-year clinical trial of the Low-Concentration Atropine for Myopia Progression (LAMP) study: phase 2 report","volume":"127","author":"Yam","year":"2020","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ophtha.2024.03.013_bib9","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ophtha.2021.10.002","article-title":"Three-year clinical trial of Low-Concentration Atropine for Myopia Progression (LAMP) study: continued versus washout: phase 3 report","volume":"129","author":"Yam","year":"2022","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ophtha.2024.03.013_bib10","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ophtha.2021.10.016","article-title":"Efficacy and safety of 8 atropine concentrations for myopia control in children: a network meta-analysis","volume":"129","author":"Ha","year":"2022","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ophtha.2024.03.013_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jamaophthalmol.2023.5610","article-title":"Atropine eye drops for myopia control in childhood-more long-term data, please","volume":"142","author":"Repka","year":"2024","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.ophtha.2024.03.013_bib12","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ophtha.2008.10.020","article-title":"Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine","volume":"116","author":"Tong","year":"2009","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ophtha.2024.03.013_bib13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ajo.2013.09.020","article-title":"Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5","volume":"157","author":"Chia","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2024.03.013_bib14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","article-title":"Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops","volume":"123","author":"Chia","year":"2016","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ophtha.2024.03.013_bib15","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.ophtha.2020.12.036","article-title":"Age effect on treatment responses to 0.05%, 0.025%, and 0.01% atropine: Low-Concentration Atropine for Myopia Progression (LAMP) study","volume":"128","author":"Li","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.03.013_bib16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ajo.2021.12.014","article-title":"The association of choroidal thickening by atropine with treatment effects for myopia: two-year clinical trial of the Low-Concentration Atropine for Myopia Progression (LAMP) study","volume":"237","author":"Yam","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ophtha.2024.03.013_bib17","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/bjo.2009.158428","article-title":"Development of a Chinese version of the National Eye Institute Visual Function Questionnaire (CHI-VFQ-25) as a tool to study patients with eye diseases in Hong Kong","volume":"93","author":"Chan","year":"2009","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2024.03.013_bib18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12874-017-0442-1","article-title":"When and how should multiple imputation be used for handling missing data in randomised clinical trials\u2014a practical guide with flowcharts","volume":"17","author":"Jakobsen","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ophtha.2024.03.013_bib19","first-page":"1","article-title":"Generalized estimating equations in longitudinal data analysis: a review and recent developments","volume":"2014","author":"Wang","year":"2014","journal-title":"Advances in Statistics"},{"issue":"4","key":"10.1016\/j.ophtha.2024.03.013_bib20","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/aje\/kwf215","article-title":"Statistical analysis of correlated data using generalized estimating equations: an orientation","volume":"157","author":"Hanley","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.ophtha.2024.03.013_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"issue":"1","key":"10.1016\/j.ophtha.2024.03.013_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/jamaophthalmol.2023.5467","article-title":"Topical atropine for childhood myopia control: the Atropine Treatment Long-Term Assessment Study","volume":"142","author":"Li","year":"2024","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"10.1016\/j.ophtha.2024.03.013_bib23","article-title":"Influence of age and race on axial elongation in myopic children","volume":"63","author":"Shamp","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.ophtha.2024.03.013_bib24","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ophtha.2023.02.020","article-title":"Efficacy in myopia control: the Low-Concentration Atropine for Myopia Progression (LAMP) study","volume":"130","author":"Bullimore","year":"2023","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ophtha.2024.03.013_bib26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10384-021-00822-y","article-title":"Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study","volume":"65","author":"Hieda","year":"2021","journal-title":"Jpn J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ophtha.2024.03.013_bib27","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1136\/bjophthalmol-2019-314819","article-title":"Low-dose (0.01%) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)-study protocol","volume":"104","author":"Azuara-Blanco","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ophtha.2024.03.013_bib28","doi-asserted-by":"crossref","first-page":"e1136","DOI":"10.1111\/aos.14166","article-title":"Efficacy of atropine 0.01% for the treatment of childhood myopia in European patients","volume":"97","author":"Sacchi","year":"2019","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2024.03.013_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/jop.2006.22.41","article-title":"Prevention of myopia progression with 0.05% atropine solution","volume":"22","author":"Lee","year":"2006","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.ophtha.2024.03.013_bib30","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/jamaophthalmol.2020.3820","article-title":"Safety and efficacy of low-dose atropine eyedrops for the treatment of myopia progression in chinese children: a randomized clinical trial","volume":"138","author":"Wei","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"10.1016\/j.ophtha.2024.03.013_bib31","first-page":"1535","article-title":"Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression","volume":"104","author":"Fu","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ophtha.2024.03.013_bib32","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ophtha.2021.01.026","article-title":"Atropine for the treatment of childhood myopia in India: multicentric randomized trial","volume":"128","author":"Saxena","year":"2021","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ophtha.2024.03.013_bib33","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/ceo.14148","article-title":"Low-concentration atropine eyedrops for myopia control in a multi-racial cohort of Australian children: a randomised clinical trial","volume":"50","author":"Lee","year":"2022","journal-title":"Clin Exp Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642024001908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642024001908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T04:12:30Z","timestamp":1728533550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642024001908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0161642024001908"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2024.03.013","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Five-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2024.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}